CAS 693-05-0

3-(methylamino)propanenitrile

Codes: IBAN-015

Application context (from source-drug indications)

OsteoporosisIbandronate Sodium Hydrate/ColecalciferolOsteoporosisIbandronate Sodium HydratePostmenopausal osteoporosisIbandronate Sodium HydrateHypercalcaemiaIbandronate Sodium HydrateBone injuryIbandronate Sodium HydrateBreast cancerIbandronate Sodium HydrateMetastatic cancerIbandronate Sodium Hydrate

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Ibandronate Sodium Hydrate/Colecalciferol	Tier C — Watch / trade	-
Ibandronate Sodium Hydrate	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Ibandronate Sodium Hydrate/ColecalciferolOptimised routesteps: 5total yield: /

3-(methyl(pentyl)amino)propanoic acid→1-bromopentane→ 3-(methylamino)propanenitrile→methyl 3-(methyl(pentyl)amino)propanoate→[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid

Ibandronate Sodium HydrateOptimised routesteps: 5total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.